Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia

Journal of Internal Medicine

Volumn 252, Issue 2, 2002, Pages 149-154

  Fabris, F ^a   Luzzatto, G ^a   Soini, B ^a   Ramon, R ^a   Scandellari, R ^a   Randi, M L ^a   Girolami, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Heparin induced thrombocytopenia; Orthopaedic surgery; Predictive factors; Thrombosis

Indexed keywords

HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTERY DISEASE; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DEATH; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SKIN NECROSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TIME; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; ORTHOPEDIC PROCEDURES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0036360550     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01021.x     Document Type: Article

References (25)

1. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia
2. Heparin-induced thrombocytopenia
3. Heparin-induced thrombocytopenia: Association with a platelet-aggregating factor and arterial thrombosis
4. White clot syndrome
5. Orgaran (Danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia
6. Heparin and platelets
7. The biological basis of immune heparin induced thrombocytopenia
8. Heparin-induced thrombocytopenia: New insights into the impact of the FcgammaRIIa-R-H131 polymorphism
9. Clinical presentation of heparin-induced thrombocytopenia
10. Laboratory diagnosis of heparin associated thrombocytopenia and comparison of platelet aggregation test, heparin induced activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay
11. Heparin-induced thrombocytopenia: Prevalence in a large cohort of patients and confirmed role of PF4/heparin complex as the main antigen for antibodies
12. Temporal aspects od heparin-induced thrombocytopenia
13. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery
14. Impact of the patient population on the risk for heparin-induced thrombocytopenia
15. Heparin-induced thrombocytopenia and thrombosis: Clinical and laboratory studies
16. Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated in a single institution
17. A 14-year study of heparin-induced thrombocytopenia
18. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin/platelet factor 4 complexes
19. Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications
20. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
21. Determination of heparin-platelet factor 4 -IgG antibodies improves the diagnosis of heparin induced thrombocytopenia
22. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
23. Redesigning heparin
24. Heparin-induced thrombocytopenia: Yet another treatment paradox
25. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia